Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1–T3, N0–N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE StudyMaria Vittoria Dieci, Marta Mion, Paolo Morandi et al.|The Oncologist|2019Cited by 37
Innovative systems for earthquake resistant masonry enclosures in RC buildingsAntónio Baio Dias, Ahmet Yakut, Francesca da Porto et al.|Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)|2014Cited by 5